Shopping Cart 0
Cart Subtotal
AED 0

Quanterix Corp (QTRX) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Quanterix Corp (Quanterix) is a life sciences company that develops and markets ultra-sensitive digital immunoassay platform that improves precision health for life sciences research and diagnostics. The company develops platform based on its proprietary digital single molecule array, Simoa detection technology that allows the detection of proteins and nucleic acids in biological samples. Quanterix's kits include components required to run tests, such as capture and detector reagents, beads, enzyme reagents and enzyme substrates. Its consumables include Simoa disks, cuvettes and disposable tips. Its technology is used for research applications in various therapeutic areas, including neurology, cardiology, oncology, inflammation and infectious diseases. The company's Simoa technology serves life science research, diagnostics and precision health screening markets. It also provides contract research services. Quanterix is headquartered in Lexington, Massachusetts, the US.

Quanterix Corp (QTRX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Quanterix Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Quanterix Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Quanterix Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Quanterix Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Quanterix Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Quanterix Corp, Medical Equipment, Deal Details 12

Venture Financing 12

Aushon BioSystems Raises Additional USD3 Million in Venture Financing 12

Aushon BioSystems Raises USD3.6 Million in Financing Round 13

Quanterix Raises USD46 Million in Series D Financing 14

Aushon BioSystems Raises USD8 million in Venture Financing 16

Quanterix Raises USD 1 Million In Venture Financing 17

Quanterix Raises USD 19 Million In Series C Financing 18

Aushon BioSystems Raises USD 5.5 Million In Venture Financing 20

Quanterix Raises USD 2 Million In Venture Financing 21

Quanterix Secures Investment In Venture Financing 22

Partnerships 23

Quanterix Enters into Licensing Agreement with Banyan Biomarkers 23

bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 24

Quanterix Enters into Agreement with DestiNA Genomics 25

ADx NeuroSciences Enters into Agreement with Quanterix 26

Quanterix Enters into Agreement with Frontage Labs 27

Quanterix, Beth Israel Deaconess And Forsyth Institute Enter Into Partnership To Develop Tuberculosis Test 28

Aushon BiosyStems Enters Into Distribution Agreement With Fisher Scientific 30

Equity Offering 31

Quanterix Raises USD73.7 Million in IPO 31

Quanterix Raises USD8.5 Million in Private Placement 33

Quanterix Invests in Immunarray 34

Acquisition 35

Lepu Medical Plans to Acquire 5.35% Stake in Quanterix for USD11 Million 35

Quanterix Corp-Key Competitors 36

Quanterix Corp-Key Employees 37

Quanterix Corp-Locations And Subsidiaries 38

Head Office 38

Other Locations & Subsidiaries 38

Recent Developments 39

Strategy And Business Planning 39

Jun 15, 2017: Frontage Laboratories Announces Partnership With Quanterix And Validation Of Simoa Hd-1 Analyzer And Software To Support Biomarker Analysis 39

Financial Announcements 40

Aug 08, 2018: Quanterix releases operating results for second quarter 2018 40

May 09, 2018: Quanterix Releases Operating Results for First Quarter 2018 41

Mar 14, 2018: Quanterix Releases Operating Results for Fourth Quarter and Fiscal Year 2017 42

Jan 10, 2018: Quanterix: Results of Operations and Financial Condition 43

Corporate Communications 44

Aug 03, 2017: Quanterix Raises USD 8.5 Million In Private Financing Led By T. Rowe Price Associates; Also Appoints Dr. Marijn Dekkers To Company'S Board Of Directors And Several Key Executives To Its Leadership Team 44

Product News 45

Oct 09, 2018: Quanterix Simoa Technology powers record number of presentations and poster sessions at ECTRIMS 2018 45

Jul 23, 2018: Quanterix' Ultra-Sensitive Technology Creates Breakthroughs in Brain Health of Military and Veterans 46

Oct 17, 2017: Dr. David Walt of Wyss Institute to Speak at Powering Precision Health 2017 47

Aug 15, 2017: Quanterix To Launch High-Sensitivity Benchtop Instrument And Assays For Multiplex Biomarker Detection 48

Jul 18, 2017: Quanterix, Partners Develop PCR-free miRNA Detection Method for Liver Toxicity Testing 49

Jul 06, 2017: Single Molecule Microrna Technology Proves Useful for Liver Toxicity Detection 50

May 17, 2017: Quanterix Launches The First Comprehensive Multiplex Panel To Study Traumatic Brain Injury Severity 51

Apr 14, 2017: Quanterix To Present Webinar On Protein Quantification And Identification In Personalized Medicine 52

Jan 05, 2017: Quanterix to Present at The 35th Annual J.P. Morgan Healthcare Conference 53

Other Significant Developments 54

Apr 27, 2018: Quanterix Marks Leadership in Accelerating Neurology Research with 100-Publication Milestone 54

Jul 18, 2017: Quanterix Boosts Investments in its Accelerator Lab to Support Rapid Growth of Simoa Technology 55

May 09, 2017: Smithers Avanza Adds Quanterix' Simoa Technology To Bioanalytical Laboratory 56

Appendix 57

Methodology 57

About GlobalData 57

Contact Us 57

Disclaimer 57


List Of Figure

List of Figures

Quanterix Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Quanterix Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Quanterix Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Quanterix Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Quanterix Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Quanterix Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Quanterix Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Quanterix Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Quanterix Corp, Medical Equipment, Key Facts, 2017 2

Quanterix Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Quanterix Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Quanterix Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Quanterix Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Quanterix Corp, Deals By Market, 2012 to YTD 2018 9

Quanterix Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Aushon BioSystems Raises Additional USD3 Million in Venture Financing 12

Aushon BioSystems Raises USD3.6 Million in Financing Round 13

Quanterix Raises USD46 Million in Series D Financing 14

Aushon BioSystems Raises USD8 million in Venture Financing 16

Quanterix Raises USD 1 Million In Venture Financing 17

Quanterix Raises USD 19 Million In Series C Financing 18

Aushon BioSystems Raises USD 5.5 Million In Venture Financing 20

Quanterix Raises USD 2 Million In Venture Financing 21

Quanterix Secures Investment In Venture Financing 22

Quanterix Enters into Licensing Agreement with Banyan Biomarkers 23

bioMerieux Enters Into Licensing Agreement With Quanterix For Simoa Technology 24

Quanterix Enters into Agreement with DestiNA Genomics 25

ADx NeuroSciences Enters into Agreement with Quanterix 26

Quanterix Enters into Agreement with Frontage Labs 27

Quanterix, Beth Israel Deaconess And Forsyth Institute Enter Into Partnership To Develop Tuberculosis Test 28

Aushon BiosyStems Enters Into Distribution Agreement With Fisher Scientific 30

Quanterix Raises USD73.7 Million in IPO 31

Quanterix Raises USD8.5 Million in Private Placement 33

Quanterix Invests in Immunarray 34

Lepu Medical Plans to Acquire 5.35% Stake in Quanterix for USD11 Million 35

Quanterix Corp, Key Competitors 36

Quanterix Corp, Key Employees 37

Quanterix Corp, Subsidiaries 38

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Quanterix Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.